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The major envelope glycoprotein, gp70, of endogenous retrovirus found in murine 
strains that are susceptible to spontaneous systemic lupus erythematosus (SLE) 1 seems 
to play an important role in their disease. The demonstration of retroviral gp70 in 
circulating blood and in deposits along with host immunoglobulins (Ig) and comple- 
ment in diseased glomeruli of mice with SLE supports the pathogenic role of gp70- 
anti-gp70  immune complexes  (IC)  (1-4).  Indeed,  four strains of mice that  develop 
SLE all have these gp70 in circulating blood, whereas immunologically normal strains 
do not  (5).  The appearance and amounts of these IC closely parallel the course of 
disease in each SLE-prone mouse (5, 6). 
It is clear that  SLE-prone mice respond immunologically to their own retroviral 
gp70 by forming antibody, which subsequently becomes part of the IC found in their 
serum  (5).  Because  multiple  immunologically  related  gp70  are expressed  in  every 
mouse  (7),  and  antibodies  to  one  or  more  of them  may  be  made  (5),  we  have 
undertaken  an  analysis  of  the  nature  of  gp70  and  anti-gp70  antibodies  in  the 
circulating  IC  of  SLE-prone  mice.  When  we  compared  the  gp70  isolated  from 
circulating  IC  (IC-gpT0) of (NZB  ×  NZW)F1  hybrid  (NZB  ×  W)  mice with  that 
found free in serum and that from several different retroviruses, the IC-gp70 resembled 
NZB xenotropic viral gpT0 (NZB-X1 gp70)  (8).  This form of gp70 accounts for most 
if not  all  of the  circulating  gp70  in  all  strains  of mice  (7).  In  exhaustive  tests  for 
specificity, anti-gp70  antibodies  isolated  from circulating  IC  (IC-anti-gp70)  prefer- 
entially bound NZB-X1 gp70 over other types of retroviral gp70. 
Materials and Methods 
Mice.  NZB  and  NZW  mice,  originally  obtained  from  the  Laboratory Animal  Center, 
Medical Research Council, Surrey, England, have been bred at Scripps Clinic and Research 
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from the  U.  S.  Public Health  Service, and  the Cecil H. and  Ida M.  Green Research Endowment. 
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1 Abbreviations used in  this paper: Con A, concanavalin A;  FeLV, feline leukemia virus; IC, immune 
complex; IC-anti-gp70, anti-gp70 antibodies isolated from the circulating IC; IC-gp70, retroviral gp70 
isolated from the circulating IC; MuLV, murine leukemia virus, NZB-X  1, xenotropic virus predominantly 
expressed in NZB mice; NZB-X2, second type of xenotropic virus induced by 5-iododeoxyuridine in NZB 
fibroblasts in vitro; NZB×W, (NZB X NZW)FI hybrid; PBS, phosphate-buffered saline; SDS-PAGE, 
sodium dodecyl suifate-polyacrylamide  gel electrophoresis; SLE, systemic lupus erythematosus; Staph A, 
Staphylococcus aureus that contained protein A. 
J. ExP. MED. ~ The Rockefeller  University Press • 0022-1007/81/05/1151 / 10 $1.00  1 15 1 
Volume 153  May 1981  1151-1160 1152  IDENTIFICATION OF IMMUNE  COMPLEX  gp70  AND ANTI-gp70 
Foundation, La Jolla, Calif. since 1965. Mating NZB females with NZW males in our animal 
colony yielded the F1 hybrids NZB×W. BXSB and MRL/Mp (IF/IF)  (designated MRL/1) 
mice were originally obtained from The Jackson Laboratory, Bar Harbor, Maine, and have 
been bred at the Scripps Clinic and Research Foundation for the past 5 yr. DBA/2, LG/J, and 
AKR mice were purchased from The Jackson Laboratory. Blood samples were collected from 
these animals by orbital sinus puncture, and the sera were stored at -20°C until use. 
Retroviruses and Retroviral Envelope Glycoprotein  gp 70.  Rauscher murine leukemia virus (MuLV), 
BALB/c xenotropic virus, and AKR ecotropic virus were obtained from the National Cancer 
Institute, Bethesda, Md.  NZB xenotropic virus (NZB-X1;  NZB clone 35), AKR xenotropic 
virus,  AKR  recombinant  virus,  and  wild  mouse  amphotropic  virus  (4070A)  were  kindly 
provided by Dr. F. C. Jensen (Scripps Clinic and Research Foundation). NIH Swiss xenotropic 
virus (RD-ATS 124) was obtained by inoculating a human rhabdomyosarcoma cell line into 
antithymocyte-treated NIH Swiss mice (9). gp70 of Rauscher MuLV was purified according to 
the procedure of Strand and August (10). gp70 from NZB-X 1, murine sera, or partially purified 
gp70 IC were purified by immunoaffinity column chromatography and sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) as previously described (7). gp70 from AKR 
ecotropic virus was a gift from Dr. A. F. Esser (Scripps Clinic and Research Foundation). 
Antisera.  Goat  anti-feline leukemia virus  (FeLV)  antisera and  goat  anti-AKR ecotropic 
virus antisera were obtained from the National Cancer Institute. Anti-Rauscher MuLV gp70 
antibodies were raised in goats by repeated injections of purified Rauscher MuLV gp70 in 
complete Freund's adjuvant.  Anti-murine IgG came  from  rabbits  immunized  by  repeated 
injections of murine IgG (Miles Laboratories, Inc., Elkhart, Ind.). 
Radiolabeling Procedures.  gp70 isolated from Rauscher MuLV, AKR ecotropic virus, NZB- 
X1 and NZB×W mouse serum were labeled with radioactive iodine (125I) by the chloramine T 
method (11). 
Radioimmunoassayfor gp70.  The concentrations of gp70 in serum samples, gradient fractions, 
or  retrovirus preparations  were  determined  by  inhibiting  the  binding  of goat  anti-FeLV 
antibody to 125I-labeled gp70 from Rauseher MuLV. The details of this assay were described 
previously (5).  A  standard  inhibition curve was established with  the buffer that  contained 
known  amounts  of gp70  from  sera of 2-mo-old NZB  mice,  and  the  concentration  of gp70 
present in tested samples was estimated by reference to the standard curve. 
In some experiments, the concentrations of gp70 in sera or retroviruses were determined by 
a  similar radioimmunoassay with 125I-labeled AKR ecotropic viral gp70 and goat anti-AKR 
ecotropic virus antibodies, gp70 of AKR ecotropic virus was used as reference antigen for the 
latter radioimmunoassay. 
Isolation of Free gp7Ofrom Sera.  Pooled sera from 7-10-too-old NZB×W female mice contain- 
ing free and Ig-eomplexed gp70 and 2-too-old DBA/2 or AKR mice containing only free gp70 
were applied to a cyanogen bromide-activated Sepharose 4B column coated with concanavalin 
A  (Con A)  (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.).  Bound 
gp70 was eluted by 0.1 M a-methyl-D-mannoside in 0.01  M  phosphate-buffered saline, pH 7.4 
(PBS). To separate free gp70 from the gp70 complexed with antibodies in the materials eluted 
from  Con  A  columns,  the  eluted  materials were  applied to  a  Sepharose 4B  column  that 
contained  Staphylococcus aureus protein  A,  which  selectively binds  Ig-complexed  gp70  (5). 
Unbound materials were concentrated and dialyzed against PBS, then applied to a 5-20% (wt: 
vol) linear sucrose density gradient in PBS and centrifuged at 36,000 rpm for 15 h at 4°C with 
a SW60 rotor in a Beckman L-75 ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.). 
The gradients were divided into 24 fractions. The presence of gp70 in each fraction was detected 
by a radioimmunoassay, and IgG was detected by radial immunodiffusion in agar with rabbit 
anti-murine IgG antisera. Materials not bound to the protein A column contained no detectable 
amounts of rapidly sedimenting Ig-complexed gp70, but did have free gp70 sedimenting in the 
5S fractions, gp70-rich fractions were reapplied to the sucrose density gradients, and gradient 
fractions containing gp70 but no detectable amounts of IgG were used as free gp70 in further 
experiments. 
Isolation oflC-gp70 and IC-Anti-gp70.  Circulating gp70 IC were obtained from pooled sera of 
7-10-mo-old' NZBXW female mice by affinity column chromatography. Serum gp70, free and 
complexed, were first isolated from the Con A column, as described in the above section, then S.  IZUI, J.  H. ELDER, P. J.  McCONAHEY, AND F. J.  DIXON  1153 
applied to a  protein A column. The bound gp70 IC were then eluted with  1 M  potassium 
thiocyanate (KSCN) in PBS. Eluates thus obtained were immediately concentrated and applied 
to a 5-20% sucrose density gradient in PBS containing 1 M KSCN as described previously (5). 
The resulting 24  fractions were immediately dialyzed against  PBS,  and  the gp70 and  IgG 
contents were determined. To obtain relatively pure IgG anti-gp70 antibodies or gp70,  the 
enriched  fractions  of each  were  passed  several  times  through  KSCN-gradients.  Gradient 
fractions containing  IgG but  not  detectable amounts of gp70 were used  as  IgG anti-gpT0 
antibodies from the IC (IC-anti-gp70) and those containing gp70 but no measurable amounts 
of IgG were used as gp70 from the IC (IC-gp70). 
Two-Dimensional Ptptidt Fingerprinting.  Tryptic peptide fingerprints were performed on im- 
mune-precipitated bands from SDS-PAGE gels as previously described (7, 12). 
Binding of  lC-Anti-gp TO to gp TO  fiom Various Sources.  Sera or retrovirus preparations containing 
constant amounts of gp70 were incubated with various amounts of IC-anti-gp70 isolated from 
NZBXW mice or goat anti-AKR ecotropic virus antisera at 4°C overnight. To determine the 
amounts ofgp70 bound to IC-anti-gp70 or goat anti-AKR ecotropic virus antisera, the mixtures 
were depleted of IgG by adsorption with 0.025 ml of packed S. aureus that contained protein A 
(Staph A; provided by Dr. M. J. Buchmeier, Scripps Clinic and Research Foundation) for 30 
min at room temperature. After the removal of IgG-bound Staph A by centrifugation,  the 
amounts of gp70 in the supernate were determined by radioimmunoassay. As a control, serum 
or retroviral gp70 were incubated with normal mouse IgG or normal goat serum and then 
treated with Staph A. From the concentrations of gp70 in both supernates, the amounts of 
gp70 bound by IC-anti-gp70 or goat antisera were calculated. It should be noted that, in the 
absence of anti-gp70 antibodies, <5% of serum gp70 or viral gp70 adsorbed to the Staph A. In 
some experiments, the mixtures were depleted of IgG by immune precipitation with rabbit 
anti-murine IgG antisera, from which anti-goat IgG activity was preabsorbed by goat IgG- 
coated immunoadsorbent columns, because anti-goat IgG activity interferes  with the radioim- 
munoassay for gp70. As a control, the mixtures were treated with normal rabbit serum. 
Results 
Characterization  of lC-gp7Ofrom  NZB×  W  Mice.  Approximately 30% of circulating 
gp70 was complexed with Ig when we processed a  serum pool obtained from 7-10- 
mo-old NZB×W female mice by quantitative absorption with Staph A. Free gp70 as 
well as gp70 complexed with anti-gp70 antibodies in this pooled serum sample were 
then  isolated  by  affinity  column  chromatography  and  sucrose  density  gradient 
ultracentrifugation. 
The isolated IC-gp70 was first characterized immunochemically by two competitive 
radioimmunoassays,  one with  anti-FeLV  antibody and  125I-Rauscher MuLV  gp70 
and the other with anti-AKR ecotropic virus antibody and x25I-AKR ecotropic viral 
gp70. Relative inhibitory activities of IC-gp70 in both radioimmunoassays were then 
compared with those of free gp70 in sera of NZBXW, DBA/2, or AKR mice and with 
those of various retroviruses. IC-gp70 efficiently inhibited the reactivity of anti-FeLV 
antibodies to 125I-Rauscher MuLV gp70, but only very slightly inhibited the binding 
of anti-AKR ecotropic virus antibodies to x25I-AKR eeotropic viral gp70 (Fig.  1). 
Inhibition  of IC-gp70  in  two  radioimmunoassays  resembled  that  by  sera  from 
NZB×W and DBA/2 mice that  predominantly contain NZB-X1  gp70 and that by 
xenotropic viruses from NZB and AKR mice and amphotropic virus from wild mice. 
In contrast, the inhibitory patterns by serum gp70 from AKR mice and by gp70 from 
both  AKR recombinant  virus and  AKR ecotropic virus differed  from that  by IC- 
gp70. AKR serum that expresses AKR ecotropic viral gp70 as well as NZB-X1 gp70, 
and AKR recombinant virus containing both xenotropic and ecotropic genomes, not 
only  competed  in  the  anti-FeLV-125I-Rauscher  MuLV  gp70,  but  also  inhibited, 1154 
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Fio.  1.  Inhibitory  pattern of competitive binding by IC-gp70, serum-free gp70, and  various 
retroviral gp70 in two radioimmunoassays: with anti-FeLV antibody and lzSI-Rauseher MuLV 
gp70 (0) and with anti-AKR ecotropic virus antibody and ~I-AKR ecotropic viral gp70 (O). 
Various concentrations  of gp70 preparations were serially  diluted in buffer. Each point represents 
the percent inhibition of  binding of  I-gp70  to antibodies in both assays at each dilution of  samples. 
though  to  a  lesser  extent,  the  binding  of z~I-AKR  ecotropic  gp70  to  anti-AKR 
ecotropic virus antibodies. AKR ecotropic virus exhibited stronger inhibitory activity 
in the assay with anti-AKR eeotropic virus antibodies and zz~I-AKR  eeotropic viral 
gp70 than in the other assay. 
Because immunochemical analysis could not distinguish  whether IC-gp70 was of 
xenotropic  origin  or  amphotropie  origin,  the  molecular  nature  of IC-gp70  was 
investigated by tryptic peptide  mapping analysis.  Shown  in  Fig.  2  are  the tryptic 
fingerprints of gp70 from the predominant xenotropic virus endogenous to NZB mice 
(NZB-X1)  (8)  (Fig. 2A), free gp70 from the serum of NZBXW mice (Fig. 2B), and 
IC-gp70 of NZBXW mice (Fig. 2C). As reported previously (7, 8), the predominant 
free gp70 of serum in NZB×W mice was identical to NZB-X1 gp70 and possessed a 
rapidly migrating peptide (Fig. 2, arrow) that was lacking from other gp70 including 
AKR ecotropic virus, amphotropic virus, and xenotropic viruses isolated from murine 
strains other than NZB and NZB×W. However, if the fingerprint of free gp70 isolated 
from serum was overexposed, markers of a second, closely related gp70 were evident 
(Fig. 2, brackets). These marker peptides were reminiscent of, but not identical to, the 
pattern  from the same  region reported previously for other xenotropie viruses  (8). S.  IZUI, J.  H. ELDER, P. J.  McCONAHEY, AND F. J.  DIXON  1155 
FiG. 2.  Tryptic peptide fingerprints of gp70 from sera of NZB×W mice and from NZB xenotropic 
virus, gp70 were isolated by immunoaffinity  chromatography and radiolahcled before analysis. (A) 
NZB-X1 gp70 from the predominant xenotropic virus of NZB mice (8); (B) free gp70 in sera from 
7-10-too-old NZB×W mice; ((2) IC-gp70 from the circulations of 7-10-too-old NZB×W mice. 
Arrows indicate a marker peptide characteristic of NZB-XI gp70. Brackets in B and C indicate 
constellation of peptides that denotes a second closely  related gpT0 present in serum. Note that both 
marker peptides are present in IC-gp70  and serum-free  gp70 as well. 
Both  the NZB-X1  marker (arrow)  and  markers of the second gp70  (brackets)  were 
present  in  IC-gp70, indicating  that  IC-gp70 were structurally  identical  to  the  free 
form of serum gp70. Moreover, the tryptic fingerprints of IC-gp70 were different from 
those of other  types of non-NZB  xenotropic  viruses,  amphotropic virus,  as well  as 
ecotropic virus (7, 8). 
Characterization of IC-Anti-gp70 Antibodies.  The binding activity of IC-anti-gp70 to 
serum  gp70  from  various  strains  of  mice  or  to  viral  gp70  of  various  retrovirus 
preparations was determined by using Staph A to precipitate gp70 bound by IC-anti- 
gp70. IC-anti-gp70 reacted almost equally well with free gp70 from sera of 2-mo-old 
mice from SLE-prone strains  (NZB, NZB×W,  MRL/1  and male BXSB)  and  from 
normal strains (NZW, LG/J, DBA/2, and female BXSB)  (Table I). When binding of 
IC-anti-gp70 to various viral gp70 was compared with that to serum gp70, only gp70 
from NZB-X 1 functioned equivalently to serum gp70 (Table I). Binding was moderate 
when gp70 from other types of non-NZB xenotropic viruses (BALB/c, AKR, or NIH 
Swiss mice) were tested. However, IC-anti-gp70 only minimally bound gp70 of AKR 
ecotropic virus, AKR recombinant virus, or Rauscher MuLV. There was essentially 
no binding to amphotropic viral gp70. Similar results were obtained when the binding 
activity was determined by the precipitation of Ig-bound gp70 with anti-murine IgG 
antisera. 
Because  the  radioimmunoassay  with  anti-FeLV  antibodies  and  x2SI-Rauscher 
MuLV  gp70  is less efficient in  detecting AKR ecotropic viral gp70  than  that  with 
anti-AKR ecotropic virus antibodies and taSI-AKR ecotropic viral gp70, the binding 
activity of IC-anti-gp70 to AKR ecotropic viral gp70 was determined by the  latter 
radioimmunoassay. However, even then, --<10% binding resulted  (Table II). 
We next used a  more quantitative method to compare the binding of IC-anti-gp70 
to several gp70.  For  this  purpose,  constant  amounts  of gp70  from NZB×W  mouse 
sera or  from retroviruses were  incubated  with  increasing  amounts  of IC-anti-gp70, 
and the percent binding by IC-anti-gp70 was determined. At all concentrations tested, 
the binding capacities of IC-anti-gp70 to NZB×W serum gp70 and to NZB-X1 gpT0 
were essentially identical (Fig. 3) and contrasted markedly to the much lower binding 
ofAKR ecotropic viral gp70. At the concentration of IC-arrti-gp70 that bound ~50% 
of serum gp70 or NZB-X1 gp70, only 10% ofAKR ecotropic viral gp70 was specifically 1156  IDENTIFICATION OF IMMUNE  COMPLEX  gp70 AND ANTI-gp70 
TABLE I 
Binding of lC-Anti-gp TO to gp 7O from Various Sources 
Source ofgp70 
Binding of gp70 in experiment* 
1  2  3 
% 
Serum:[: 
NZBXW9  66.5§  58.4  54.1 
NZB~  64. l  NTll  NT 
MRL/19  63.1  NT  NT 
BXSBd  61.9  NT  NT 
BXSB9  57.5  NT  NT 
NZW~  50.8  NT  NT 
LG/Jd  62.9  NT  NT 
DBA/2d  66.8  NT  NT 
Retrovirus 
NZB-X 1  59.5  52.6  41.8 
BALB/c xenotrope  24.9  NT  NT 
AKR xenotrope  25.4  NT  NT 
NIH Swiss xenotrope  27.6  NT  NT 
AKR ecotmpe  10.7  10.2  9.0 
AKR recombinant  11.3  t 3. l  NT 
Rauseher MuLV  6.2  0.0  6.5 
Amphotrope  0.0  0.0  2.4 
* Binding  of gp70  by  IG-anti-gp70  was  determined  by  quantitating  the 
amounts  of gp70 absorbed specifically with Staph A in the presence of IG- 
anti-gp70.  Without  IC-anti-gp70,  Staph  A  absorbed <5%  of serum  or 
retroviral gp70. 
:~ Pooled from 10 2-mo-old mice. 
§ Mean of triplicates. 
II Not tested. 
precipitated. Because  10 times less IC-anti-gp70 bound  ~10% of NZB-X1  gp70, the 
binding affinity of IC-anti-gp70 to NZB-X1  gp70 was ~  10 times greater than that to 
AKR  ecotropic viral gp70. 
As further confirmation of this high affinity, we investigated whether IC-anti-gp70 
preferentially react  with  NZB-X1  gp70  when  offered  a  mixture  containing  AKR 
ecotropic viral gp70 as well. For this purpose, IC-anti-gp70 was incubated with AKR 
mouse serum  that  contains both  NZB-XI  gp70 and  AKR  ecotropic viral gp70.  To 
differentiate the binding of these gp70, we used two radioimmunoassays: the one with 
anti-FeLV antisera and  12ZI-Rauscher MuLV  gp70  detects  the binding of NZB-X1 
gp70 and to a  lesser degree AKR  ecotropic viral gp70; the second radioimmunoassay 
with anti-AKR ecotropic virus antibodies and x2~I-AKR ecotropic viral gp70 detects 
only AKR ecotropic viral gp70 efficiently. According to the former radioimmunoassay, 
IC-anti-gp70 bound  a  significant  amount  of gp70  from  AKR  serum,  whereas  the 
latter radioimmunoassay showed essentially no  binding  (Table II).  Similarly, when 
IC-anti-gp70 was incubated with the mixture of NZB-X1  virus and AKR  ecotropic 
virus, significant binding was observed only by using the former radioimmunoassay S.  IZUI, J.  H.  ELDER,  P.  J.  McCONAHEY,  AND  F.  J.  DIXON  1157 
60  W  Serum 
4~  ~lenotrope 
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iC-Anti-gp70 (~1) 
FzG. 3.  Binding of IC-anti-gpT0 to serum-free gp70  from sera of 2-too-old NZB×W mice  (C)), 
NZB-X1 gp70 (O), and AKR ecotropic viral gpT0 (gt). Constant amounts of gp70 were incubated 
with increasing amounts of IC-anti-gp70 at 4°C overnight and the percent binding of these gp70 by 
IC-anti-gp70 was determined by using Staph A to precipitate gp70 bound to IC-anti-gp70. Each 
point represents the mean of triplicates. 
TABLE  II 
Binding of lC-Anti-gp70 to NZB Xenotropic Viral and AKR Ecotropic Viral gp70 
Anti-AKR 
Antibodies  Source of gp70  Anti-FeLV*  virus:~ 
12SI.Rgp70  I~SI_AK  R 
gp70 
% 
IC-anti-gp70  AKR serumll  62.2¶  0.0 
IC-anti-gp70  NZB xenotropic virus  46.4  0.0 
IC-anti-gp70  AKR ecotropic virus  9.6  8.2 
IC-anti-gpT0  NZB  xenotropic virus +  29.7  0.0 
AKR ecotropic virus 
Anti-AKR virus§  AKR serum  55.1  66.4 
* Radioimmunoassay with goat anti-FeLV antibody and I~I-Rauscher MuLV gp70 
(t~I-Rgp70) that recognizes both NZB xenotropic and AKR ecotropic viral gp70 
efficiently. 
Radioimmunoassay with goat  anti-AKR ecotropic virus antibody and  Iz~I-AKR 
ecotropic viral gp70 that recognizes only AKR ecotropic viral gp70 efficiently. 
§ Obtained from goats immunized with AKR ecotropic virus. 
U  Containing both NZB xenotropic viral and AKR ecotropic viral gp70. 
¶ Mean of triplicates. 
that detects NZB-X1  gp70. This result clearly indicates that IC-anti-gp70 preferen- 
tially recognized NZB-X1  gp70 over AKR ecotropic viral gp70. It should be noted 
that the serum from goats immunized with AKR ecotropic virus bound AKR serum 
gp70 in both radioimmunoassays. 
Discussion 
Our results concern  the nature of IC-gp70  in  the several  strains of mice that  are 
genetically predisposed to murine SLE, produce antibodies against their own serum 1158  IDENTIFICATION OF IMMUNE COMPLEX gp70 AND ANTI-gp70 
gp70, and consequently form IC  (5, 6).  We have now demonstrated  that  these IC- 
gp70  have  the  immunologic and  structural  characteristics  of gp70  from  the  NZB 
xenotropic virus NZB-X1 expressed dominantly in sera of all SLE-prone and normal 
mice, and distinct from gp70 belonging to viruses with other tropisms. This conclusion 
is supported by several experimental observations. First, structural analysis of the IC- 
gp70 by tryptic peptide maps indicate that the IC-gp70 are similar to NZB-X1 gp70, 
but  differ from  gp70  of AKR  ecotropic virus,  amphotropic  virus,  and  xenotropic 
viruses isolated from murine strains other than NZB and  NZB×W mice, including 
NIH Swiss,  AKR, NZW, C57BL/6, BALB/c, and wild mice (7, 8). Second, the IC- 
gp70 do not show structural relatedness either to gp70 of a second type of xenotropic 
virus induced by 5-iododeoxyuridine in NZB fibroblasts in vitro (NZB-X2)  (8) or to 
gp70 expressed on the surfaces of thymocytes and spleen cells (8). Both NZB-X2 and 
cell surface-associated gp70 are structurally different from NZB-X1  gp70, but have 
molecular characteristics similar to those ofxenotropic viral gp70 isolated from strains 
other  than  NZB  and  NZB×W  mice  (8).  Third,  the  characterization  of IC-gp70 
determined by two different competitive radioimmunoassays  that  distinguish AKR 
ecotropic viral gp70 from xenotropic viral gp70 reveals that the IC-gp70 do not carry 
the determinants specific for the AKR ecotropic viral gp70, ruling out the possible 
involvement of AKR ecotropic virus or recombinant virus formed between ecotropic 
virus and xenotropic virus (12). 
Tryptic peptide  maps  of the  IC-gp70  reaffirm that  the  IC-gp70  are structurally 
identical to gp70 circulating free in sera of not only SLE-prone mice but also normal 
murine strains (7). It should be pointed out that this free gp70 in serum is molecularly 
unchanged during the course of murine SLE, excluding the possibility that affected 
mice produce a  new or modified type of gp70  that  elicits their immune responses. 
Because IC-gp70 carry unidentified peptides that are not components of any retroviral 
gp70 tested, including NZB-X1  gp70, the involvement of retroviral gp70 other than 
NZB-X1 gp70 is not excluded. However, it should be emphasized that these uniden- 
tified  peptides  are  also  present  in  freely circulating  gp70  of every murine  strain. 
Therefore, one must conclude that  IC-gp70 is not a  unique type, but  is commonly 
expressed in sera of virtually all mice. 
The  immunologic specificity of IC-anti-gp70  antibodies was  assayed in  terms of 
binding to various retroviral gp70. The results show that IC-anti-gp70 are primarily 
directed to  NZB-X1  gp70  as well as serum  gp70,  with  minimal  cross-reactivity to 
other retroviral gp70. This conclusion is drawn from the following evidence. First, IC- 
anti-gp70 binds NZB-X1  gp70 and serum gp70 considerably better than the other 
retroviral gp70 tested. Second, quantitative studies show that the affinity of IC-anti- 
gp70 for NZB-X1 gp70 and for serum gp70 is 10 times higher than for AKR ecotropic 
viral gp70. Finally, IC-anti-gp70 selectively recognize NZB-X1 gp70 when incubated 
with a  mixture of NZB-XI  gp70 and AKR ecotropic viral gp70.  This observation 
excludes  the  possibility  that  anti-AKR  ecotropic  viral  gp70  antibodies  or  anti- 
Rauscher  MuLV  gp70  antibodies  occasionally  found  in  sera  of  NZB×W  and 
MRL/1 mice (5, 13) participate in the formation of circulating gp70-anti-gp70 IC. In 
fact, the presence of such antibodies in sera of NZBXW or MRL/1  mice does not 
correlate at all either with serum levels of gp70-anti-gp70 IC or with the development 
of renal disease (5).  Further, these antibodies are found in several strains of normal 
mice such as NZW and LG/J, although two other SLE strains, NZB and BXSB mice S.  IZUI, J.  ft.  ELDER, P. J.  McCONAHEY, AND F. J.  DIXON  1159 
that develop gp70-anti-gp70 IC, do not produce detectable amounts of these antibod- 
ies (5,  14). 
It is noteworthy that IC-anti-gp70 react equally well with free gp70 in sera of SLE 
strains of mice and in all normal strains of mice tested. This confirms that sera from 
all  these  mice  express  the  same  type  of gp70,  which  is  similar  to  NZB-XI  gp70, 
although  AKR mice express an additional  AKR ecotropic viral gp70  in  their sera. 
Furthermore, the antibody involved in this IC formation is not directed to a  type of 
gp70 expressed only in  the  SLE-prone mice, but  rather is directed  to a  ubiquitous 
molecule of all the mice. 
Our observations that the IC-gp70 are identical to free gp70 in sera of all murine 
strains and that the IC-anti-gp70 reacts preferentially with NZB-X1 gp70 as well as 
serum gp70 suggest  that  the abnormality of SLE mice manifested as production  of 
antibodies to their own retroviral serum gp70 and formation of IC is not the result of 
an  unusual  kind  of gp70,  but  rather  of the  unique  ability  of these  mice to  make 
antibody to their own NZB-X1 gp70. Such an abnormal immune response may result 
from their well-known immunologic dysfunction, for example, lack ofT cell regulatory 
function  (15,  t6), loss of suppressor T  cells (17,  18),  and/or increased B cell activity 
(19, 20). Therefore, like responses to many other autoantigens, the anti-gp70 response 
of mice with  SLE may reflect  the abundant  formation of Ig reactive with multiple 
available antigens, among them NZB-X1 gp70, by hyperactive B cells. 
Summary 
Retroviral gp70 and anti-gp70 antibodies were isolated from circulating immune 
complexes (IC) of 7-10-too-old  (NZB  X  NZW)F1 mice, after which the nature and 
origin of this gp70 (IC-gp70) and the immunologic characteristics of these anti-gp70 
antibodies (IC-anti-gp70) were investigated. Immunochemical and structural analyses 
of IC-gp70  demonstrated  that  among  multiple  immunologically  related  gp70  ex- 
pressed in all mice, the IC-gp70 had characteristics similar to those of NZB xenotropic 
viral gp70 (NZB-X1 gp70)  that is commonly present in sera of virtually all strains of 
mice. The study of binding by IC-anti-gp70 antibodies to retroviral gp70 from various 
sources  showed  that  the  IC-anti-gp70 were primarily directed  to NZB-X1  gp70  as 
well  as  serum  gp70.  These  data  strongly  suggest  that  the  abnormality  of murine 
strains with systemic lupus erythematosus causing them to produce antibodies to their 
own xenotropic  viral gp70  and  to  form IC with  serum  gp70  is  not  based on  their 
expression of an unusual  type of gp70, but rather their ability to make an antibody 
to NZB-X1 gp70, probably as a result of their immunologic dysfunction. 
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